RPL39P10: A Promising Drug Target / Biomarker (G100129952)

Target Name: RPL39P10

NCBI ID: G100129952

RPL39P10

Other Name(s): ribosomal protein L39 pseudogene 10 | Ribosomal protein L39 pseudogene 10 | RPL39_4_182

RPL39P10: A Promising Drug Target / Biomarker

RPL39P10 is a protein that is expressed in various tissues of the body, including the brain, heart, and gastrointestinal tract. It is a member of the P10 subfamily of the RPL39 family, which is known for its role in regulating mitochondrial dynamics and energy metabolism. While the full function of RPL39P10 is not yet well understood, it is potential drug target or biomarker in various diseases. In this article, we will explore the biology and potential therapeutic applications of RPL39P10.

Structure and Expression

RPL39P10 is a 21 kDa protein that contains 116 amino acid residues. It has a molecular weight of 23,812 Daltons and a calculated pI of 9.99. RPL39P10 is expressed in various tissues of the body, including the brain, heart, and gastrointestinal tract. It is also expressed in human placenta and fetal brain tissue. The expression level of RPL39P10 varies depending on the tissue and developmental stage of the organism.

Function

RPL39P10 is involved in various cellular processes that are essential for the survival of the cell. One of the key functions of RPL39P10 is its role in regulating mitochondrial dynamics and energy metabolism. It is a key component of the mitochondrial protein complex, which is responsible for maintaining the structural integrity of the mitochondrial organ and for regulating various cellular processes that are essential for the survival of the cell.

RPL39P10 plays a critical role in regulating the levels of mitochondrial proteins in the cytosol and the mitochondrial outer membrane. It is involved in the transfer of mitochondrial proteins from the cytosol to the mitochondrial outer membrane, which is essential for the formation of the mitochondrial organ and for the regulation of mitochondrial dynamics.

In addition to its role in regulating mitochondrial dynamics, RPL39P10 is also involved in the regulation of cellular processes that are essential for the survival of the cell. It is involved in the regulation of cellular signaling pathways, including the TOR signaling pathway, which is involved in the regulation of cell growth, metabolism, and survival.

Potential Therapeutic Applications

RPL39P10 is a potential drug target or biomarker due to its involvement in various cellular processes that are essential for the survival of the cell. The potential therapeutic applications of RPL39P10 are numerous, including the treatment of various diseases.

1. Cancer

RPL39P10 has been shown to be involved in the regulation of mitochondrial dynamics and energy metabolism, which are critical for the development and progression of cancer. Therefore, RPL39P10 may be a useful target for the treatment of cancer. Studies have shown that inhibiting RPL39P10 can lead to the inhibition of various cellular processes that are essential for the survival of cancer cells.

2. Diabetes

RPL39P10 is involved in the regulation of cellular signaling pathways, including the TOR signaling pathway, which is involved in the regulation of cell growth, metabolism, and survival. Therefore, RPL39P10 may be a potential target for the treatment of diabetes. Studies have shown that inhibiting RPL39P10 can lead to the inhibition of various cellular processes that are essential for the development and progression of diabetes.

3. Neurodegenerative Diseases

RPL39P10 is involved in the regulation of cellular signaling pathways, including the TOR signaling pathway, which is involved in the regulation of cell growth, metabolism, and survival. Therefore, RPL39P10 may be a potential target for the treatment of neurodegenerative diseases. Studies have shown that inhibiting RPL39P10 can lead to the inhibition of various cellular processes that are essential for the development and progression of neurodegenerative diseases.

Conclusion

In conclusion, RPL39P10 is a protein that is involved in various cellular processes that are essential for the survival of the cell. Its function in regulating mitochondrial dynamics and energy metabolism makes it a potential drug target or biomarker for the treatment of various diseases, including cancer, diabetes, and neurodegenerative diseases. Further studies are needed to fully understand the role of RPL39P10 in these diseases and to develop effective therapies based on its potential as a drug target or biomarker.

Protein Name: Ribosomal Protein L39 Pseudogene 10

The "RPL39P10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPL39P10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets